VIVUS (VVUS) Resumes Trading +17%

July 18, 2012 7:15 AM EDT Send to a Friend
Share of VIVUS Inc. (Nasdaq: VVUS) resume trading up 17% after the FDA approved obesity drug Qsymia.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Momentum Movers, Trader Talk, Trading Halts

Add Your Comment